Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies.

Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies. Spine (Phila Pa 1976). 2002 Dec 01; 27(23):2662-73.

View in: PubMed

subject areas

Awards and Prizes
Bone Morphogenetic Protein 2
Bone Morphogenetic Proteins
Bone Substitutes
Bone Transplantation
Calcium Phosphates
Drug Implants
Female
Follow-Up Studies
Humans
Ilium
Internal Fixators
Intervertebral Disc Displacement
Low Back Pain
Lumbosacral Region
Male
Middle Aged
Pilot Projects
Prospective Studies
Recombinant Proteins
Reoperation
Spinal Fusion
Transforming Growth Factor beta
Treatment Outcome